BUZZ - Insmed shares surge after Bloomberg reports Sanofi is interested in an acquisition
路透社2026/11/19 15:51November 19 - ** According to Bloomberg, US pharmaceutical company Insmed (INSM.O) may become an acquisition target of French pharmaceutical giant Sanofi SASY.PA. Boosted by this news, the company's share price surged 17% to $140.25.
** INSM's share price is on track for its biggest single-day gain since August, and its highest closing price since April.
** Bloomberg, citing sources familiar with the matter, reported that Sanofi is considering acquiring INSM.
** According to data from London Stock Exchange Group (LSEG), the average rating of 25 analysts covering INSM is "Buy" with a median target price of $195.
** So far this year, INSM's share price has fallen 19.7%, while the S&P 500 Health Care Index .SPXHC has risen 15.2%.
(To accommodate non-English speakers, Reuters has automated translations of its reports into several other languages. Because automated translations may contain inaccuracies or lack the desired context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for reader convenience. Reuters accepts no responsibility for any damage or loss caused by the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Important Cardano News and ADA Price Update: November 19

BUZZ-Anthropic set to soar in historic debut after record $81 billion IPO
Anthropic shares expected to open 26.5% above $83 IPO price